GENEVA, Sept. 18 -- SCITHERM THERAPEUTICS CORPORATION filed a patent application (US2026/017671) for “TRPV1 AGONIST AND USES THEREOF”. With publication no. WO/2026/187886, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07C 235/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....